Literature DB >> 27708967

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a patient with systemic lupus erythematosus and lupus nephritis.

Lütfi Akyol1, Soner Önem1, Metin Özgen1, Mehmet Sayarlıoğlu1.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by several immunological abnormalities. We wish to communicate the case of a patient with SLE and lupus nephritis (LN) who developed pseudothrombocytopenia. Pseudothrombocytopenia can occur in patients with SLE and LN and should be considered when diagnosing patients with thrombocytopenia without bleeding.

Entities:  

Keywords:  SLE; lupus nephritis; pseudothrombocytopenia

Year:  2015        PMID： 27708967      PMCID： PMC5042272          DOI： 10.5152/eurjrheum.2015.0115

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN： 2147-9720


  10 in total

1.  [A case of late-onset SLE complicated with EDTA-dependent pseudothrombocytopenia].

Authors:  A Irisawa; S Kaise; Y Kumada; Y Sato; T Nishimaki; R Kasukawa; T Moritoh
Journal:  Ryumachi       Date:  1992-10

2.  Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.

Authors:  M Kuwana; J Kaburaki; Y Okazaki; H Miyazaki; Y Ikeda
Journal:  Rheumatology (Oxford)       Date:  2006-01-17       Impact factor: 7.580

3.  Documented sudden onset of pseudothrombocytopenia.

Authors:  M E Gschwandtner; P Siostrzonek; C Bodinger; T Neunteufl; C Zauner; G Heinz; G Maurer; S Panzer
Journal:  Ann Hematol       Date:  1997-06       Impact factor: 3.673

4.  Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab.

Authors:  H Stiegler; Y Fischer; S Steiner; B E Strauer; H Reinauer
Journal:  Ann Hematol       Date:  2000-03       Impact factor: 3.673

5.  [Pseudothrombocytopenia caused by low molecular weight IgM in rheumatoid arthritis: a case report].

Authors:  T Murayama; S Nakasaki
Journal:  Nihon Naika Gakkai Zasshi       Date:  1987-07

6.  EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up.

Authors:  N Bizzaro
Journal:  Am J Hematol       Date:  1995-10       Impact factor: 10.047

Review 7.  The busy life of regulatory T cells in systemic lupus erythematosus.

Authors:  Antonio La Cava
Journal:  Discov Med       Date:  2009-06       Impact factor: 2.970

8.  EDTA-dependent pseudothrombocytopenia: further insights and recommendations for prevention of a clinically threatening artifact.

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2012-08       Impact factor: 3.694

Review 9.  Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new.

Authors:  Kam Newman; Mohammad Bagher Owlia; Ihab El-Hemaidi; Mojtaba Akhtari
Journal:  Autoimmun Rev       Date:  2013-02-24       Impact factor: 9.754

10.  Effective estimation of correct platelet counts in pseudothrombocytopenia using an alternative anticoagulant based on magnesium salt.

Authors:  Peter Schuff-Werner; Michael Steiner; Sebastian Fenger; Hans-Jürgen Gross; Alexa Bierlich; Katrin Dreissiger; Steffen Mannuß; Gabriele Siegert; Maximilian Bachem; Peter Kohlschein
Journal:  Br J Haematol       Date:  2013-06-29       Impact factor: 6.998
  10 in total
  1 in total

Review 1.  Pseudothrombocytopenia-A Review on Causes, Occurrence and Clinical Implications.

Authors:  Benjamin Lardinois; Julien Favresse; Bernard Chatelain; Giuseppe Lippi; François Mullier
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.